Dianthus Share Price

Dianthus Share Price

NASDAQ: DNTH | Mid Cap | Healthcare
$83.92
-$3.02 (-3.47%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Dianthus Stock Performance

Open
$87.79
Prev. Close
$86.94
Circuit Range
N/A
Day Range
$83.67 - $88.60
Year Range
$35.85 - $117.78
Volume
64,876
Average Traded
$85.21

Dianthus Share Price Today

As of 19 November 2026, Dianthus Therapeutics, Inc.'s share price is $83.92. The stock opened at $87.79, compared to its previous close of $86.94. During today's trading session, Dianthus Therapeutics, Inc.'s share price traded between $83.67 and $88.60, with an average price of $86.13. Over the past 52 weeks, the stock has recorded a high of $117.78 and a low of $35.85. In terms of performance, Dianthus Therapeutics, Inc.'s share price has declined by 9.72% over the last six months and is up 90.90% on a year-on-year basis.

Dianthus Share Price Chart

Line chart of the Dianthus price trend over the selected period. The price fell overall, ranging from 83.89 to 88.91, ending at 83.92.
$83.67$88.60
L
Show Current Price
H

Dianthus Stock Fundamentals & Key Indicators

Market Cap
$3.24B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.59
Revenue (TTM)
$2.04B
Return On Equity (TTM)
-16.28%
Profit Margin
-7957.84%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
27.61%

Dianthus Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.28$0.46$0.76$1.21
Net Profit-$64.43-$40.83-$50.22-$46.64
Net Profit Margin-23010.71%-8876.09%-6607.89%-3854.55%
Income ChangeN/A36.63%-23.00%7.13%

Dianthus Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$2.83$6.24$2.04
Net Profit-$43.56-$84.97-$162.34
Net Profit Margin-1539.22%-1361.70%-7957.84%
Income ChangeN/A-95.06%-91.06%

Dianthus Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets121.4893.11.95
Current Assets409.44280.9177.45
Total Assets530.92374.01179.41
Non Current Liabilities6.793.080.9
Current Liabilities30.7318.459.63
Total Liabilities37.5221.5310.54
Shareholders' Equity493.4352.48168.87

Dianthus Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-129.06-78.18-36.86
Investing-122.83-286.8120.25
Financing280.13255.62133.57

About Dianthus

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

Dianthus Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$83.57
$83.91
+1.70%
Oct 2026
$89.04
$82.50
-6.40%
Sep 2026
$105.55
$88.14
-20.93%
Aug 2026
$104.56
$111.48
+4.26%
Jul 2026
$96.93
$106.92
+9.69%
Jun 2026
$91.78
$97.47
+4.86%
May 2026
$89.30
$92.96
+5.83%
Apr 2026
$86.57
$87.84
+4.73%
Mar 2026
$53.84
$83.87
+52.10%
Feb 2026
$52.94
$55.14
+3.15%
Jan 2026
$41.00
$53.45
+29.71%
Dec 2025
$43.50
$41.21
-6.26%

Dianthus Share Price FAQs